CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading researcher profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

Robert B. Laprairie - Medical Cannabis Research Engine

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Researchers/Profile

Researcher profile

Robert B. Laprairie

OPENALEX: A5037819900↗ORCID: 0000-0002-9994-433X↗

Affiliations

Organizations

Dalhousie Universityauthorship · CA Scripps Research Instituteauthorship · US University of Saskatchewanauthorship · CA

Public evidence

6 connected articles

Characterization of cannabinoid plasma concentration, maternal health, and cytokine levels in a rat model of prenatal <i>Cannabis</i> smoke exposure2023 · bioRxiv New Insights into Bitopic Orthosteric/Allosteric Ligands of Cannabinoid Receptor Type 2.2023 · Europe PMC Novel Potent and Selective Agonists of the GPR55 Receptor Based on the 3-Benzylquinolin-2(1<i>H</i>)-One Scaffold.2022 · Europe PMC Impact of the mouse estrus cycle on cannabinoid receptor agonist-induced molecular and behavioral outcomes.2022 · Europe PMC Modulation of type 1 cannabinoid receptor activity by cannabinoid by-products from <i>Cannabis sativa</i> and non-cannabis phytomolecules.2022 · Europe PMC In vitro and in vivo pharmacological activity of minor cannabinoids isolated from Cannabis sativa.2020 · Europe PMC

Matched by exact identifiers only. Profile data: Corpus/OpenAlex.